⌘K
Loading ticker…
Rallybio Corporation Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, Rallybio Corporation Common Stock (RLYB) has a 3-month relative strength percentile of 95 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 95. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 3.4%, relative volume 1.30×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
3m RS is 95, Market Stance is mixed at 47, A/D rating A
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
RLYB is in a stage 2 uptrend, week 12. Currently in a 18-day base; basing ADR 3.4% (broad 5.7%). VCP detected: no. RS line below base-start high. Distance from 50d / 200d: 17.2% / 102.3%.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
RLYB is held by 2 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $713K notional.
Top 2 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $713K |
| VXFVanguard Extended Market ETF | 0.00% | $292K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | RLYB Jan avg: -13.68% median: -8.42% win: 25% σ: 21.03% n: 4 2022-04-12 → 2026-05-29 | RLYB Feb avg: 29.10% median: 30.09% win: 75% σ: 38.53% n: 4 2022-04-12 → 2026-05-29 | RLYB Mar avg: -9.57% median: -14.91% win: 25% σ: 20.43% n: 4 2022-04-12 → 2026-05-29 | RLYB Apr avg: -6.27% median: 0.11% win: 60% σ: 27.03% n: 5 2022-04-12 → 2026-05-29 | RLYB May avg: 22.79% median: 32.84% win: 60% σ: 30.51% n: 5 2022-04-12 → 2026-05-29 | RLYB Jun avg: -18.95% median: -20.36% win: 25% σ: 22.06% n: 4 2022-04-12 → 2026-05-29 (current) | RLYB Jul avg: 17.63% median: 14.62% win: 100% σ: 16.02% n: 4 2022-04-12 → 2026-05-29 | RLYB Aug avg: 1.38% median: 2.18% win: 50% σ: 18.16% n: 4 2022-04-12 → 2026-05-29 | RLYB Sep avg: -2.74% median: -2.63% win: 50% σ: 27.83% n: 4 2022-04-12 → 2026-05-29 | RLYB Oct avg: 4.62% median: 6.33% win: 50% σ: 33.65% n: 4 2022-04-12 → 2026-05-29 | RLYB Nov avg: -21.83% median: -23.19% win: 25% σ: 30.96% n: 4 2022-04-12 → 2026-05-29 | RLYB Dec avg: 6.65% median: 9.72% win: 75% σ: 18.29% n: 4 2022-04-12 → 2026-05-29 |